0 item $0.00

Professor Eylem Levelt

DPhil, University of Oxford | MSc in Clinical Trials, University of Oxford | MRCP, Royal College of Physicians, UK | CCT in Cardiology, UK

I am an imaging cardiologist specialising in cardiovascular magnetic resonance (CMR) and magnetic resonance spectroscopy (MRS), with a focus on heart disease in individuals with diabetes.

My research aims to improve cardiovascular outcomes for people with diabetes through collaborative, interdisciplinary efforts. I investigate mechanisms of heart disease in diabetes using advanced imaging techniques and develop novel treatment strategies through randomised clinical trials.

Since beginning my DPhil at Oxford, I've dedicated my career to understanding and modifying cardiovascular risk in diabetic patients. I completed an MSc in Clinical Trials at Oxford with support from the European Society of Cardiology.

In 2020, I was awarded the Wellcome Trust Clinical Career Development Fellowship. I served as Associate Professor of Cardiology at the University of Leeds in 2022 before being promoted to Professor of Cardiology in 2023.

In 2025, I joined the Baker Heart and Diabetes Institute and established the Cardiometabolic Imaging lab.

Awards

  • British Cardiovascular Society Michael Davies Early Career Award (2024)
  • European Association of Cardiovascular Imaging (EACVI) Leaders of Tomorrow Fellowship Programme (2022–2024)
  • Winner, Women as One International Escalator Award, research (2022–2023)
  • European Society of Cardiology, Educational Grant for Clinical Trials MSc, University of Oxford (2021–2024)
  • Bernard and Joan Marshall Research Prize Competition finalist, British Society of Cardiovascular Research Autumn Meeting (2017)
  • Runner-up, Elsevier/Oxford Centre for Diabetes, Endocrinology, and Metabolism (University of Oxford) Annual Junior Research Prizes in Diabetes, Endocrinology & Metabolism (2015)

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more